Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals.
We isolated peroxisome biogenesis mutants from Chinese hamster ovary (CHO) cells, using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/ UV) method and wild-type CHO-K1 cells that had been stably transfected with cDNA encoding Pex2p (formerly peroxisome assembly factor-1, PAF-1). Three mutant cell clones, ZP110, ZP111, and ZP114, showed cytosolic localization of catalase, thereby indicating a defect in peroxisome biogenesis, whereas ZP112 and ZP113 contained fewer but larger catalase-positive particles. Mutant ZP115 displayed an aberrant, tubular structure immunoreactive to anti-catalase antibody. Mutants lacking morphologically recognizable peroxisomes also showed the typical peroxisome assembly-defective phenotype such as severe loss of catalase latency and resistance to 12-(1'-pyrene)dodecanoic acid (P12)/UV treatment. ZP110 and ZP111, and ZP114 were found to belong to two novel complementation groups, respectively, by complementation group analysis with cDNA transfection and cell fusion. Cell fusion with fibroblasts from patients with peroxisome biogenesis disorders such as Zellweger syndrome revealed that ZP110 and ZP114 could not be classified to any of human complementation groups. Thus, ZP110/ZP111 and ZP114 are the first, two peroxisome-deficient cell mutants of newly identified complementation groups distinct from the ten mammalian groups previously characterized.
Tateishi
K
K
Department of Biology, Faculty of Science, Kyushu University, Fukuoka/Japan.
Okumoto
K
K
Shimozawa
N
N
Tsukamoto
T
T
Osumi
T
T
Suzuki
Y
Y
Kondo
N
N
Okano
I
I
Fujiki
Y
Y
D000102:Acetyl-CoA C-Acyltransferase / Q000096:biosynthesis; D042962:Acyl-CoA Oxidase; D000818:Animals; D016466:CHO Cells; D002374:Catalase / Q000032:analysis; D002459:Cell Fusion; D006224:Cricetinae; D003600:Cytosol / Q000201:enzymology; D004072:Digitonin / Q000494:pharmacology; D005347:Fibroblasts; D005816:Genetic Complementation Test; D006801:Humans; D007850:Lauric Acids / Q000494:pharmacology; D008322:Mammals; D008565:Membrane Proteins / Q000235:genetics; D008830:Microbodies / Q000201:enzymology* / Q000648:ultrastructure*; D016296:Mutagenesis; D009154:Mutation; D010088:Oxidoreductases / Q000096:biosynthesis; D000074428:Peroxisomal Biogenesis Factor 2; D014466:Ultraviolet Rays; D015211:Zellweger Syndrome / Q000378:metabolism
D007850:Lauric Acids; D008565:Membrane Proteins; D000074428:Peroxisomal Biogenesis Factor 2; C040596:12-(1-pyrene)dodecanoic acid; D010088:Oxidoreductases; D002374:Catalase; D042962:Acyl-CoA Oxidase; D000102:Acetyl-CoA C-Acyltransferase; D004072:Digitonin